감정이 배뇨에 미치는 영향

참고문헌 (60)

1. "Micturition and the soul", 493, pp.15~20 (2005)
2. "Disruptive effects of overactive bladderand urge urinary incontinence in younger women", 119, pp.16~23
3. "Predictorsof symptom severity in patients with chronic prostatitis andinterstitial cystitis", 175, pp.963~966 (2006)
4. "Men's experiencesof having lower urinary tract symptoms", 94, pp.563~567 (2004)
5. "Depressivesymptoms and quality of life in patients with interstitialcystitis", 167, pp.1763~1767 (2002)
6. "Pain and depressionexperienced by women with interstitial cystitis", 31, pp.67~81 (2000)
7. "Treatment of the overactive bladder", 59, pp.18~24 (2002)
8. "The role of corticotropin releasing factor and its antagonist,astressin, on micturition in the rat", 123, pp.26~35 (2005)
9. "The medical management of depression", 353, pp.1819~1834 (2005)
10. "Anxiety disordersin the 21st century", 11, pp.344~353 (2005)
11. "The roleof corticotropin-releasing factor in depression and anxietydisorders", 160, pp.1~12 (1999)
12. "Depression and incontinence", 19, pp.351~357 (2001)
13. "Urinary incontinence and depression", 162, pp.82~84 (1999)
14. "Alterations in voiding frequency and cystometryin the clomipramine induced model of endogenous depressionand reversal with fluoxetine", 170, pp.2067~2071 (2003)
15. "Efficacy of escitalopramin the treatment of major depressive disorder comparedwith conventional selective serotonin reuptake inhibitors andvenlafaxine XR", 31, pp.122~131 (2006)
16. "Role of 5-HT receptors in treatmentof overactive bladder", 39, pp.599~607 (2003)
17. "A case-control studyto examine any association between idiopathic detrusor instabilityand gastrointestinal tract disorder, and between irritablebowel syndrome and urinary tract disorder", 79, pp.865~878 (1997)
18. "Is there an irritable bladder in the irritable bowel syndrome?", 104, pp.1409~1412 (1997)
19. "Major depression and irritable bowel syndrome:is there a relationship", 56, pp.363~367 (1995)
20. "CRF1 receptorsignaling pathways are involved in stress-related alterations ofcolonic function and viscerosensitivity", 141, pp.1321~1330 (2004)
21. "Role of peripheral CRF signalling pathwaysin stress-related alterations of gut motility and mucosalfunction", 16, pp.137~142 (2004)
22. "Uropsychiatry", 63, pp.273~7 (1964)
23. "Sequential treatment of moodand anxiety disorders", 66, pp.1392~1400 (2005)
24. "Long-term goals in the managementof acute and chronic anxiety disorders", 49, pp.51~63 (2004)
25. "Neural control", pp.363~422 (2004), Plymbridge Distributors Ltd
26. "Central nervouscontrol of micturition and urine storage", 41, pp.117~132 (2005)
27. "Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion ofcorticotropin and beta-endorphin", 213, pp.1394~7 (1981)
28. "Non-peptidic CRF1 receptor antagonistsfor the treatment of anxiety, depression and stress disorders", 1, pp.467~493 (2002)
29. "Are CRFreceptor antagonists potential antidepressants?", 16, pp.81~87 (2001)
30. "Corticotropin-releasing factorreceptor antagonists in affective disorders and drug dependence- an update", 5, pp.147~165 (2006)
31. "Central regulation of micturitionin the rat the corticotropin-releasing hormone from Barrington'snucleus", 196, pp.185~8 (1995)
32. "Corticotropin releasing factor", 172, pp.2570~2573 (2004)
33. "Impact of the state of arousal and stressneuropeptides on urodynamic function in the freely movingrat", 26, pp.1~31 (2006)
34. "Expressionof corticotropin releasing factor (CRF) and CRF receptors inmicturition pathways after cyclophosphamide (CYP)-inducedcystitis", 13 (2006)
35. "Non-peptidic CRF1 receptor antagonistsfor the treatment of anxiety, depression and stressdisorders", 1, pp.467~493 (2002)
36. "Depression and anxiety:role of the locus coeruleusand corticotropin-releasing factor", 34, pp.561~72 (1994)
37. "Corticotropinreleasingfactor and neuropeptide Y:role in emotional integration", 17, pp.80~5 (1994)
38. "Corticotropin-releasing hormone receptorsubtypes and emotion", 46, pp.1480~1508 (1999)
39. "Systematic review and guide to selectionof selective serotonin reuptake inhibitors", 57, pp.507~533 (1999)
40. "Pharmacokinetic-pharmacodynamic relationship ofthe selective serotonin reuptake inhibitors", 31, pp.444~469 (1996)
41. "Selective serotonin reuptake inhibitors:pharmacologicprofiles and potential therapeutic distinctions", 28, pp.1359~69 (1994)
42. "The role of central 5-hydroxytryptamine (5-HT,serotonin) receptors in the control of micturition", 147, pp.120~131 (2006)
43. "Role of supraspinal serotonin receptors for micturitionin normal conscious rats", pp.225~230 (2002)
44. "Influence of central serotonergic mechanismson lower urinary tract function", 59, pp.30~36 (2002)
45. "Female, but notmale, serotonin reuptake transporter (5-HTT) knockout miceexhibit bladder instability", 122, pp.107~110 (2005)
46. "Not so selective serotonin reuptake inhibitors", 59, pp.343~344 (1998)
47. "Using secondary binding properties to select anot so selective serotonin reuptake inhibitors", 59, pp.642~643 (1998)
48. "Efficacy and tolerability of citalopram inthe treatment of late-life anxiety disorders", 162, pp.146~150 (2005)
49. "Escitalopram versus citalopram", 174, pp.163~176 (2004)
50. "Newer antidepressants", 65, pp.46~52 (2004)
51. "Escitalopram", 40, pp.121~131 (2004)
52. "Escitalopram", 23, pp.1185~1209 (2003)
53. "Anatomy of the central neural pathways controllingthe lower urinary tract", 34, pp.2~5 (1998)
54. "Integrative control of the lower urinary tract", pp.14725~14740 (2006)
55. "Pharmacology of the lower urinarytract", 41, pp.691~721 (2001)
56. "Central nervouscontrol of micturition and urine storage", 41, pp.117~132 (2005)
57. "Cerebral control of bladder function", 5, pp.348~352 (2004)
58. "Voluntary pelvic floor muscle control-an fMRIstudy", 28, pp.1~9 (2006)
59. "Brain controlof normal and overactive bladder", 174, pp.1862~1867 (2005)
60. "Functional imaging andthe central control of the bladder", 493, pp.27~35 (2005)

관련 논문AI추천